FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134933135> ?p ?o ?g. }

• W2134933135 endingPage "1342" @default.
• W2134933135 startingPage "1334" @default.
• W2134933135 abstract "The aim of this study was to assess the safety and tolerability, pharmacokinetics and pharmacodynamics of LY3000328 when administered as single escalating doses to healthy volunteers.This was a phase 1, placebo-controlled, dose escalation study with LY3000328 in 21 healthy male volunteers. Subjects were administered escalating LY3000328 doses up to 300 mg with food in this single dose study. Blood samples were collected at set times post-dose for the assessment of LY3000328 pharmacokinetics and the measurement of cathepsin S (CatS) activity, CatS mass and calculated CatS specific activity.All doses of LY3000328 were well tolerated, with linear pharmacokinetics up to the 300 mg dose. The pharmacodynamic activity of LY3000328 was measured ex vivo showing a biphasic response to LY3000328, where CatS activity declines, then returns to baseline, and then increases to a level above baseline. CatS mass was also assessed post-dose which increased in a dose-dependent manner, and continued to increase after LY3000328 had been cleared from the body. CatS specific activity was additionally calculated to normalize CatS activity for changes in CatS mass. This demonstrated the increase in CatS activity was attributable to the increase in CatS mass detected in plasma.A specific inhibitor of CatS which is cleared quickly from plasma may produce a transient decrease in plasma CatS activity which is followed by a more prolonged increase in plasma CatS mass which may have implications for the future clinical development of inhibitors of CatS." @default.
• W2134933135 created "2016-06-24" @default.
• W2134933135 creator A5018189101 @default.
• W2134933135 creator A5040460958 @default.
• W2134933135 creator A5045351924 @default.
• W2134933135 creator A5048944847 @default.
• W2134933135 creator A5057449551 @default.
• W2134933135 creator A5061729979 @default.
• W2134933135 creator A5087381976 @default.
• W2134933135 date "2014-11-20" @default.
• W2134933135 modified "2023-10-14" @default.
• W2134933135 title "Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects" @default.
• W2134933135 cites W1967480208 @default.
• W2134933135 cites W1968738407 @default.
• W2134933135 cites W1972553581 @default.
• W2134933135 cites W1972624770 @default.
• W2134933135 cites W1977015656 @default.
• W2134933135 cites W1994641823 @default.
• W2134933135 cites W2003044125 @default.
• W2134933135 cites W2022948423 @default.
• W2134933135 cites W2030241666 @default.
• W2134933135 cites W2030298613 @default.
• W2134933135 cites W2051865476 @default.
• W2134933135 cites W2068051174 @default.
• W2134933135 cites W2069102936 @default.
• W2134933135 cites W2075729810 @default.
• W2134933135 cites W2083106544 @default.
• W2134933135 cites W2095403662 @default.
• W2134933135 cites W2104047638 @default.
• W2134933135 cites W2110592414 @default.
• W2134933135 cites W2140293820 @default.
• W2134933135 cites W2168700225 @default.
• W2134933135 cites W2323804541 @default.
• W2134933135 cites W4239747187 @default.
• W2134933135 doi "https://doi.org/10.1111/bcp.12470" @default.
• W2134933135 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4256622" @default.
• W2134933135 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25039273" @default.
• W2134933135 hasPublicationYear "2014" @default.
• W2134933135 type Work @default.
• W2134933135 sameAs 2134933135 @default.
• W2134933135 citedByCount "22" @default.
• W2134933135 countsByYear W21349331352014 @default.
• W2134933135 countsByYear W21349331352015 @default.
• W2134933135 countsByYear W21349331352016 @default.
• W2134933135 countsByYear W21349331352017 @default.
• W2134933135 countsByYear W21349331352018 @default.
• W2134933135 countsByYear W21349331352019 @default.
• W2134933135 countsByYear W21349331352020 @default.
• W2134933135 countsByYear W21349331352022 @default.
• W2134933135 countsByYear W21349331352023 @default.
• W2134933135 crossrefType "journal-article" @default.
• W2134933135 hasAuthorship W2134933135A5018189101 @default.
• W2134933135 hasAuthorship W2134933135A5040460958 @default.
• W2134933135 hasAuthorship W2134933135A5045351924 @default.
• W2134933135 hasAuthorship W2134933135A5048944847 @default.
• W2134933135 hasAuthorship W2134933135A5057449551 @default.
• W2134933135 hasAuthorship W2134933135A5061729979 @default.
• W2134933135 hasAuthorship W2134933135A5087381976 @default.
• W2134933135 hasBestOaLocation W21349331351 @default.
• W2134933135 hasConcept C111113717 @default.
• W2134933135 hasConcept C112705442 @default.
• W2134933135 hasConcept C126322002 @default.
• W2134933135 hasConcept C126894567 @default.
• W2134933135 hasConcept C138944611 @default.
• W2134933135 hasConcept C142724271 @default.
• W2134933135 hasConcept C197934379 @default.
• W2134933135 hasConcept C204787440 @default.
• W2134933135 hasConcept C27081682 @default.
• W2134933135 hasConcept C2778375690 @default.
• W2134933135 hasConcept C2779904517 @default.
• W2134933135 hasConcept C71924100 @default.
• W2134933135 hasConcept C87813604 @default.
• W2134933135 hasConcept C98274493 @default.
• W2134933135 hasConceptScore W2134933135C111113717 @default.
• W2134933135 hasConceptScore W2134933135C112705442 @default.
• W2134933135 hasConceptScore W2134933135C126322002 @default.
• W2134933135 hasConceptScore W2134933135C126894567 @default.
• W2134933135 hasConceptScore W2134933135C138944611 @default.
• W2134933135 hasConceptScore W2134933135C142724271 @default.
• W2134933135 hasConceptScore W2134933135C197934379 @default.
• W2134933135 hasConceptScore W2134933135C204787440 @default.
• W2134933135 hasConceptScore W2134933135C27081682 @default.
• W2134933135 hasConceptScore W2134933135C2778375690 @default.
• W2134933135 hasConceptScore W2134933135C2779904517 @default.
• W2134933135 hasConceptScore W2134933135C71924100 @default.
• W2134933135 hasConceptScore W2134933135C87813604 @default.
• W2134933135 hasConceptScore W2134933135C98274493 @default.
• W2134933135 hasFunder F4320307758 @default.
• W2134933135 hasIssue "6" @default.
• W2134933135 hasLocation W21349331351 @default.
• W2134933135 hasLocation W21349331352 @default.
• W2134933135 hasLocation W21349331353 @default.
• W2134933135 hasLocation W21349331354 @default.
• W2134933135 hasOpenAccess W2134933135 @default.
• W2134933135 hasPrimaryLocation W21349331351 @default.
• W2134933135 hasRelatedWork W1977160484 @default.
• W2134933135 hasRelatedWork W2028648326 @default.
• W2134933135 hasRelatedWork W2112620969 @default.

• next